Clinical trial
Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure
NCT03133520 is registered in ClinicalTrials.gov with Kursat Gundogan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure
- Lead sponsor
- Kursat Gundogan
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2016
- Completion date
- September 14, 2018
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute hypoxemic respiratory failure, hematologic malignancy